HIV prevalence and risk behaviors of male injection drug users in Cairo, Egypt

AIDS

Volumn 24, Issue SUPPL. 2, 2010, Pages

  Soliman, Cherif ^a   Rahman, Ihab A ^a   Shawky, Sherine ^b   Bahaa, Tarek ^a   Elkamhawi, Sherif ^a   Sattar, Ali Abd El ^a   Oraby, Doaa ^a   Khaled, Dina ^a   Feyisetan, Bamikale ^a   Salah, Ehab ^a   Taher, Zein El ^a   Sayed, Nasr El ^a  

^a AMERICAN UNIVERSITY IN CAIRO   (Egypt)

^b Social Research Center of the American University in Cairo   (Egypt)

Author keywords

Egypt; HIV; injection drug users; respondent driven sampling; risk behavior

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; CONDOM; CONTROLLED STUDY; DIAGNOSTIC TEST; EGYPT; EPIDEMIC; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NEEDLE; PRIORITY JOURNAL; PROSTITUTION; SAFE SEX; SEXUALLY TRANSMITTED DISEASE; SYRINGE;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CROSS-SECTIONAL STUDIES; EGYPT; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; PREVALENCE; QUESTIONNAIRES; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 77954585544     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/01.aids.0000386731.94800.e6     Document Type: Article

References (27)

1. UNAIDS/WHO/UNICEF. Epidemiological fact sheet, Egypt, 2008 Update. [Accessed 8 March 2010].
2. Watts D, Constantine N, Sheba M, Kamal M, Callahan J, Kilpatrick M. Prevalence of HIV infection in Egypt over four years of surveillance (1986-1990). J Trop Med Hyg 1993; 96:113-117.
3. Soliman C, Abd El Sattar A, Abd El Mobdy A, Behets F, Dalla-bettas G, Rakha M, et al. Evaluation of selected reproductive health infections in various Egyptian population groups in Greater Cairo. MOHP, USAID, IMPACT/FHI; Cairo; 2002.
4. UNAIDS. The changing HIV epidemic in Europe and Central Asia 2004. [Accessed 8 March 2010].
5. UNAIDS/WHO. AIDS Epidemic Update December 2006. [Accessed 8 March 2010].
6. UNODC. Rapid assessment of trends and patterns of drug abuse in Egypt. Final report undertaken in cooperation with MOHP, Egypt 2001
7. Ministry of Health and Population. AIDS/HIV surveillance report. Egypt; 26 July 2006
8. Ministry of Health and Population. Central Laboratories VCT report. Egypt; 30 September 2006.
9. Family Health International. Behavioral surveillance surveys: guidelines for repeated behavior surveys in populations at risk for HIV. Arlington, VA: Family Health International; 2000.
10. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl 1997; 44:174-199.
11. Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl 2002; 49:11-34.
12. Magnani R, Sabin K, Saidel T, Heckathorn DD. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 2005; 19:S67-S72.
13. Soueif M. Use of psychoactive drugs among students: fieldwork in Egypt. National Center of Social and Criminal Research, Office of the Permanent Program on Drug Research, Egypt; 1992.
14. Soueif M. Epidemiological picture of drug abuse and addiction among Egyptian females university students. National Center of Social and Criminal Research, Office of the Permanent Program on Drug Research, Egypt; 1995
15. Ministry of Health and Population. AIDS/HIV surveillance report. Egypt; 30 June 2009.
16. Talaat M, El-Oun S, Kandeel A, Abu-Rabei W, Bodenschatz C, Lohiniva A, et al. Overview of injection practices in two governorates in Egypt. Trop Med Int Health 2003; 8:234-241.
17. UNODC, NAP, UNAIDS Secretariat. HIV risk behaviour among problem substance abusers in Cairo; 2004.
18. UNODC. HIV risk-behaviors of problem drug users in Greater Cairo August 2004.
19. Aceijas C,Stimson GV, HickmanM,RhodesT.Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18:2295-2303. (Pubitemid 39620222)
20. El-Ghazzawi E, Hunsmann G, Schneider J. Low prevalence of antibodies to HIV-1 and HTLV-I in Alexandria, Egypt. AIDS Forsch 1987; 2:639.
21. Saleh E, McFarland W, Rutherford G, Mandel J, El-Shazaly M, Coates T. Sentinel surveillance for HIV and markers for high risk behaviors among STD clinic attendees in Alexandria, Egypt. XIII International AIDS Conference, Durban, South Africa, Poster MoPeC2398. XIII International AIDS Conference; 2000.
22. El-Ghazzawi E, Drew L, Hamdy L, El-Sherbini E, Sadek Sel D, Saleh E. Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt. J Egypt Public Health Assoc 1995; 70:127-150.
23. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372:1733-1817.
24. Abu-Raddad LJ, Hilma N, Mumtaz G, Benekirane M, Akala FA, Reidner G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS 2010 2010; 24(suppl 2):S5-S23.
25. Khattab H, Younis N, Zurayk H. Women, reproduction, and health in rural Egypt: the Giza Study. Cairo: The American University of Cairo Press; 1999.
26. El-Sayed N, Gomatos P, Rodier G, Wierzba T, Darwish A, Khashaba S, et al. Seroprevalence survey of Egyptian tourism workers for HBV, HCV, HIV and Treponema Pallidum infections: association of HCV infections with specific regions of Egypt. Am J Trop Med Hyg 1996; 55:179-184.
27. El-Zayadi AR, Badran HM, Barakat EM, Attia Mel D, Shawky S, Mohamed MK, et al. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol 2005; 11:5193-5198.